GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NDT Pharmaceuticals Inc (OTCPK:NDTP) » Definitions » FCF Yield %

NDTP (NDT Pharmaceuticals) FCF Yield % : 0.00 (As of Sep. 24, 2024)


View and export this data going back to 2006. Start your Free Trial

What is NDT Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, NDT Pharmaceuticals's Trailing 12-Month Free Cash Flow is $-0.08 Mil, and Market Cap is $11.84 Mil. Therefore, NDT Pharmaceuticals's FCF Yield % for today is 0.00%.

The historical rank and industry rank for NDT Pharmaceuticals's FCF Yield % or its related term are showing as below:


NDTP's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -13.655
* Ranked among companies with meaningful FCF Yield % only.

NDT Pharmaceuticals's FCF Margin % for the quarter that ended in Jun. 2008 was 0.00%.


NDT Pharmaceuticals FCF Yield % Historical Data

The historical data trend for NDT Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NDT Pharmaceuticals FCF Yield % Chart

NDT Pharmaceuticals Annual Data
Trend Dec05 Dec06 Dec07
FCF Yield %
- - -

NDT Pharmaceuticals Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.39 -0.07

Competitive Comparison of NDT Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, NDT Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NDT Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NDT Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where NDT Pharmaceuticals's FCF Yield % falls into.



NDT Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

NDT Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2007 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.039 / 0
=N/A%

NDT Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Jun. 2008 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.008 * 4 / 42.7735
=-0.07%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NDT Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


NDT Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of NDT Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


NDT Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
7325 Oswego Road, Liverpool, NY, USA, 13090
NDT Pharmaceuticals Inc is a biotechnology company focused on developing revolutionary therapies for severe neurological disorders associated with traumatic brain injury. Its Nanoscale Particle Complex (NPC) technology represents the leading edge of phospholipid-based nano-encapsulation delivery systems (less than 100 nanometers in diameter; mean diameter of 40 nanometers in current liquid product samples with the capability to engineer significantly smaller nanocarrier particles) that create instant delivery of payloads into the bloodstream, beginning through the membranes of the mouth.
Executives
Francisco Kent Carasquero director, officer: Secretary 1057 EAST 21ST AVENUE, CANADA, VANCOUVER BC A1 V5V 1S6

NDT Pharmaceuticals Headlines

No Headlines